Nigeria vs Rwanda: Statin use vs. average non-HDL cholesterol levels

Nigeria
2.6
in 2018
Rwanda
2.6
in 2018
Nigeria rank
187th
Rwanda rank
187th

Statin use vs. average non-HDL cholesterol levels over time

  • Nigeria
  • Rwanda
0123198019992018

How they compare

Nigeria currently reports 2.6 against 2.6 in Rwanda, a difference of 0.

The two have swapped places 5 times across 39 shared years of data; in 1980 it was Nigeria ahead.

Nigeria ranks 187th and Rwanda ranks 187th of 191 countries.

Across the 4 decades both report, Nigeria averaged higher in 2 and Rwanda in 1.

Head to head by decade

Decade Nigeria Rwanda Difference Ahead
1980s 2.14 2.11 0.03 Nigeria
1990s 2.26 2.27 0.01 Rwanda
2000s 2.43 2.43 0
2010s 2.57 2.52 0.0444 Nigeria

Averages of every year both report within each decade.

Frequently asked questions

Which has higher statin use vs. average non-hdl cholesterol levels, Nigeria or Rwanda?
Nigeria, at 2.6 against 2.6 in Rwanda as of 2018.
What is the difference in statin use vs. average non-hdl cholesterol levels between Nigeria and Rwanda?
0, with Nigeria ahead.
How many years of comparable data are there for Nigeria and Rwanda?
39 years are reported by both, from 1980 to 2018.
How do Nigeria and Rwanda rank globally for statin use vs. average non-hdl cholesterol levels?
Nigeria ranks 187th and Rwanda ranks 187th of 191 countries.
Where does this data come from?
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.